Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inogen, Inc stock logo
INGN
Inogen
$8.16
-4.0%
$7.96
$5.70
$12.91
$229.84M1.8188,710 shs118,515 shs
Nephros Inc. stock logo
NEPH
Nephros
$5.40
$4.24
$1.36
$5.97
$57.24M1.3282,725 shs109,310 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$3.90
-4.9%
$4.06
$3.60
$11.00
$236.89M1.891.33 million shs1.79 million shs
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$4.32
-2.3%
$4.66
$3.42
$5.88
$220.41M0.47141,092 shs146,606 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inogen, Inc stock logo
INGN
Inogen
-4.00%-5.66%-1.92%+17.92%-9.33%
Nephros Inc. stock logo
NEPH
Nephros
0.00%+13.21%+26.46%+50.00%+262.44%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-4.88%-0.76%+3.17%-22.92%-33.67%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-2.26%-6.49%-8.67%-11.66%+1.41%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inogen, Inc stock logo
INGN
Inogen
$8.16
-4.0%
$7.96
$5.70
$12.91
$229.84M1.8188,710 shs118,515 shs
Nephros Inc. stock logo
NEPH
Nephros
$5.40
$4.24
$1.36
$5.97
$57.24M1.3282,725 shs109,310 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$3.90
-4.9%
$4.06
$3.60
$11.00
$236.89M1.891.33 million shs1.79 million shs
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$4.32
-2.3%
$4.66
$3.42
$5.88
$220.41M0.47141,092 shs146,606 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inogen, Inc stock logo
INGN
Inogen
-4.00%-5.66%-1.92%+17.92%-9.33%
Nephros Inc. stock logo
NEPH
Nephros
0.00%+13.21%+26.46%+50.00%+262.44%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-4.88%-0.76%+3.17%-22.92%-33.67%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-2.26%-6.49%-8.67%-11.66%+1.41%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inogen, Inc stock logo
INGN
Inogen
2.00
Hold$11.0034.80% Upside
Nephros Inc. stock logo
NEPH
Nephros
2.67
Moderate Buy$5.501.85% Upside
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
3.00
Buy$8.50117.95% Upside
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
3.00
Buy$10.90152.31% Upside

Current Analyst Ratings Breakdown

Latest NEPH, TLSI, INGN, and NNOX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Nephros Inc. stock logo
NEPH
Nephros
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
10/8/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Inogen, Inc stock logo
INGN
Inogen
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Nephros Inc. stock logo
NEPH
Nephros
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/27/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/19/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$8.00
8/13/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$10.00 ➝ $8.00
8/11/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
8/8/2025
Nephros Inc. stock logo
NEPH
Nephros
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$4.50 ➝ $6.00
(Data available from 10/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inogen, Inc stock logo
INGN
Inogen
$335.70M0.66N/AN/A$7.30 per share1.12
Nephros Inc. stock logo
NEPH
Nephros
$14.16M4.04$0.02 per share269.85$0.81 per share6.67
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$11.28M19.98N/AN/A$3.27 per share1.19
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$29.43M7.32N/AN/A($0.83) per share-5.20
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inogen, Inc stock logo
INGN
Inogen
-$35.89M-$1.06N/AN/AN/A-7.58%-13.77%-8.52%11/6/2025 (Estimated)
Nephros Inc. stock logo
NEPH
Nephros
$70K$0.1245.00N/A7.95%14.89%11.64%11/6/2025 (Estimated)
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$53.52M-$0.90N/AN/AN/A-468.29%-32.09%-28.73%11/20/2025 (Estimated)
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$30.05M-$1.18N/AN/AN/A-86.61%N/A-116.50%11/13/2025 (Estimated)

Latest NEPH, TLSI, INGN, and NNOX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2025Q3 2025
Inogen, Inc stock logo
INGN
Inogen
-$0.24N/AN/AN/A$92.20 millionN/A
11/6/2025Q3 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.02N/AN/AN/A$3.87 millionN/A
8/12/2025Q2 2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.15-$0.23-$0.08-$0.23$3.20 million$3.04 million
8/12/2025Q2 2025
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$0.22-$0.27-$0.05-$0.27$10.69 million$11.21 million
8/7/2025Q2 2025
Inogen, Inc stock logo
INGN
Inogen
-$0.22-$0.15+$0.07-$0.15$90.40 million$92.28 million
8/7/2025Q2 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.0250$0.02+$0.0450$0.02$3.60 million$4.40 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Inogen, Inc stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/AN/AN/AN/AN/A
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inogen, Inc stock logo
INGN
Inogen
N/A
3.03
2.67
Nephros Inc. stock logo
NEPH
Nephros
N/A
5.41
4.14
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A
4.19
4.03
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
N/A
4.08
3.68

Institutional Ownership

CompanyInstitutional Ownership
Inogen, Inc stock logo
INGN
Inogen
89.94%
Nephros Inc. stock logo
NEPH
Nephros
41.10%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
21.49%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
2.58%

Insider Ownership

CompanyInsider Ownership
Inogen, Inc stock logo
INGN
Inogen
1.46%
Nephros Inc. stock logo
NEPH
Nephros
6.70%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
7.74%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
27.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inogen, Inc stock logo
INGN
Inogen
1,03027.04 million26.65 millionOptionable
Nephros Inc. stock logo
NEPH
Nephros
3010.60 million9.89 millionNot Optionable
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
19057.78 million53.31 millionOptionable
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
10649.87 million36.15 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Inogen stock logo

Inogen NASDAQ:INGN

$8.16 -0.34 (-4.00%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$8.14 -0.03 (-0.31%)
As of 10/10/2025 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Nephros stock logo

Nephros NASDAQ:NEPH

$5.40 0.00 (0.00%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$5.06 -0.34 (-6.28%)
As of 10/10/2025 06:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Nano-X Imaging stock logo

Nano-X Imaging NASDAQ:NNOX

$3.90 -0.20 (-4.88%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$3.90 0.00 (0.00%)
As of 10/10/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

TriSalus Life Sciences stock logo

TriSalus Life Sciences NASDAQ:TLSI

$4.32 -0.10 (-2.26%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$4.32 0.00 (0.00%)
As of 10/10/2025 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.